Glutathione S-transferase polymorphisms in thyroid cancer patients

Cancer Letters

Volumn 190, Issue 1, 2003, Pages 37-44

  Hernández, Alba ^a   Céspedes, Walkiria ^a   Xamena, Noel ^a   Surrallés, Jordi ^a   Creus, Amadeu ^a   Galofré, Pere ^b   Marcos, Ricardo ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

GSTM1; GSTP1; GSTT1; Thyroid cancer

Indexed keywords

CARCINOGEN; GLUTATHIONE TRANSFERASE; MUTAGENIC AGENT; SCAVENGER;

ADULT; AGE; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; FOLLICULAR CARCINOMA; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SEX; THYROID CANCER;

LETHRINIDAE;

EID: 0037428861     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00580-3     Document Type: Article

References (32)

1. Hayes J.D., Pulford D.J. The glutathione-S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30:1995;445-460.
2. Taningher M., Malacarne D., Izzotti A., Ugolini D., Parodi S. Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat. Res. 436:1999;227-261.
3. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat. Res. 463:2000;247-283.
4. Seidegard J., Pero R.W. The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum. Genet. 69:1985;21-28.
5. Seidegard J., Vorachek W.R., Pero R.W., Pearson W.R. Hereditary differences in the expression of the human glutathione transferase activity on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA. 85:1988;7293-7297.
6. Akslen L.A., Haldorsen T., Thoresen S.O., Glattre E. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res. 51:1991;1234-1241.
7. Robbins J., Merino M.J., Boice J.D. Jr., Ron E., Ain K.B., Alexander R., Norton J.A., Reynolds J. Thyroid cancer: a lethal endocrine neoplasm. Ann. Intern. Med. 115:1991;133-147.
8. Ron E., Modan B. Thyroid. Schottenfeld D., Fraumeni J. Cancer Epidemiology and Prevention. 1982;837-854 W.B. Saunders, Philadelphia, PA.
9. Kingman S. Thyroid cancer rises after Chernobyl. Br. Med. J. 305:1992;601-602.
10. Galanti M.R., Sparén P., Karlsson A., Grimelius L., Ekbom A. Is residence in areas of endemic goiter a risk factor for thyroid cancer? Int. J. Cancer. 61:1995;615-621.
11. Nedelcheva Kristensen V.N., Andersen T.I., Erikstein B., Geitvik G., Skovlund E., Nesland J.M., Borrensen-Dale A.L. Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients. Pharmacogenetics. 8:1998;441-447.
12. Caporaso N., Goldstein A. Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics. 5:1995;59-63.
13. Lin D., Meyer D.J., Ketterer B., Lang N.P., Kadlubar F.F. Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res. 54:1994;4920-4926.
14. Mulders T.M., Keizer H.J., Breimer D.D., Mulder G.J. In vivo characterization and modulation of the glutathione/glutathione S-transferase system in cancer patients. Drug Metab. Rev. 27:1995;191-229.
15. Franceschi S., Boyle P., Maisonneuve P., La Vecchia C., Burt A.D., Kerr D.J., Farlane G.J. The epidemiology of thyroid carcinoma. Crit. Rev. Oncogen. 4:1991;25-52.
16. Hard G.C. Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis. Environ. Health Perspect. 106:1998;427-436.
17. Steenland K., Cedillo L., Tucker J., Hines C., Sorensen K., Deddens J., Cruz V. Thyroid hormones and cytogenetic outcomes in backpack sprayers using ethylenebis(dithiocarbamate) (EBCD) fungicides in Mexico. Environ. Health Perspect. 105:1997;1126-1130.
18. Hallquist A., Hardell L., Degerman A., Boquist L. Occupational exposure and thyroid cancer: results of a case-control study. Eur. J. Cancer Prev. 2:1993;345-349.
19. Wingren G.B., Axelson O. Occupational and environmental determinants for benign thyroid disease and follicular thyroid cancer. Int. J. Occup. Environ. Health. 3:1997;89-94.
20. Knudsen N., Bulow I., Laurberg P., Perrild H., Ovesen L., Jorgensen T. Alcohol consumption is associated with reduced prevalence of goitre and solitary thyroid nodules. Clin. Endocrinol. 55:2001;41-46.
21. Vassilopoulou-Sellin R., Schultz P.N., Haynie T.P. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after radioactive iodine therapy. Cancer. 78:1996;493-501.
22. Fontana X., Peyrotte I., Valente E., Rossi C., Ettore F., Namer M., Bussier F. Glutathione S-transferase mu 1 (GSTM1): susceptibility gene of breast cancer (review in French). Bull. Cancer. 84:1997;35-40.
23. Rydberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Ogreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
24. Garte S., Caspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10:2001;1239-1248.
25. Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ. Health Perspect. 107:(Suppl. 1):1999;37-47.
26. Mack W.J., Preston-Martin S., Bernstein L., Qian D., Xiang M. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles county females. Cancer Epidemiol. Biomarkers Prev. 8:1999;991-997.
27. Chen C.-L., Liu Q., Relling M.V. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics. 6:1996;187-191.
28. Singhal S.S., Saxena M., Awasthi S., Mukhtar H., Zaidi S.I., Ahmad H., Awasthi Y.C. Glutathione S-transferases of the human skin: qualitative and quantitative differences in men and women. Biochim. Biophys. Acta. 1163:1993;266-272.
29. Singhal S.S., Saxena M., Awasthi S., Ahmad H., Sharma R., Awasthi Y.C. Gender related differences in the expression and characteristics of glutathione S-transferases in human colon. Biochim. Biophys. Acta. 1171:1992;19-26.
30. Stroombergen M.C., Wairing R.H. Determination of glutathione S-transferase μ and θ polymorphisms in neurological disease. Hum. Exp. Toxicol. 18:1999;141-145.
31. Chenevix-Trench G., Young J., Coggan M., Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis. 16:1995;1655-1657.
32. Kote-Jarai Z., Easton D., Edwards S.M., Jefferies S., Durocher F., Jackson R.A., Singh R., Ardern-Jones A., Murkin A., Dearnaley D.P., Shearer R., Kirby R., Houlston R., Eeles R. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics. 11:2001;325-330.